Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL262808

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC3=NC(/N=C(\N)N4CCC(C)CC4)=NC3=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O

Basic Information

ChEMBL ID CHEMBL262808
Phase Preclinical
Structure Type MOL
InChI Key OGYQRGGCLKAOQM-MSWQDXEVSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

693.9
MW (Da)
3.05
ALogP
10
HBA
4
HBD
203.5
PSA (Ų)
0.15
QED
1
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C36H51N7O7
MW 693.85
Aromatic Rings 0
Heavy Atoms 50
NP-Likeness 1.63

Activity Summary

IC50 1 meas. best 6.82

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
SK-BR-3
CHEMBL613834
IC50 6.82 6.82 150.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
SK-BR-3 IC50 = 150.0 nM 6.82 Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-... 7562911

Literature References

PubMed DOI Target Context # Activities
7562911 10.1021/jm00019a010 SK-BR-3 2

Data from ChEMBL 36 via Core Engine